Skip to content

Effect of Taping in the Hemiplegic Patient With a Deficit of the Footbrowers

A Pilot Study of the Effect of Taping in the Hemiplegic Patient With a Deficit of the Footbrowers

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03284606
Acronym
NEUROTAP
Enrollment
7
Registered
2017-09-15
Start date
2017-09-01
Completion date
2021-12-31
Last updated
2022-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia

Brief summary

A majority of people undergoing rehabilitation following a stroke have a deficit of the dorsal flexors of the foot. The implementation of rehabilitation techniques in accordance with the recommendations of learned societies is not sufficient to compensate for this deficit. Also Kinesio Taping's method of Dr. Kenzo Kase has caught our attention by its action on muscle, joint, circulatory and pain functions. The use of taping would increase the duration of stimulation of the muscles of the dorsiflexors of the foot which would facilitate the motor recovery. Data from the literature do not support the conclusion that taping is effective, but no studies evaluating the efficacy of this technique in the foot-lift deficiency of the hemiplegic patient have been found. The investigators hypothesize that the use of taping in conjunction with common rehabilitation for hemiplegic patients following a stroke improves the stimulation of the muscles of the dorsiflexors of the foot with a positive impact on the walking.

Interventions

DEVICETAPING

Taping in conjunction with common rehabilitation for hemiplegic patients

PROCEDURECommon rehabilitation

Common rehabilitation for hemiplegic patients

Sponsors

Groupement Interrégional de Recherche Clinique et d'Innovation
CollaboratorOTHER
University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with a stroke occurring in a period ranging from 15 days to a month before inclusion and presenting left or right hemiplegia. * Voluntary motricity of the dorsal flexors of the foot greater than or equal to 1 on the scale of Held and Pierrot Deseilligny * Quadriceps voluntary motor skill greater than or equal to 2 on the scale of Held and Pierrot Deseilligny * Informed consent of the patient.

Exclusion criteria

* \- Evolutive neurological disease leading to cognitive impairment (Alzheimer's, Parkinson's, Multiple sclerosis ...) * Pre-stroke neurological sequelae * Achilles tendon elongation or tendinous transfer surgery. * Spasticity of the sural triceps greater than 2 on the modified Ashworth scale * Injection of botulinum toxin * Patients under guardianship, curatorships or under safeguard of justice. * Allergy to glue, skin lesions located on the zone of laying of the bands * Complex Regional Pain Symptom of the Ankle

Design outcomes

Primary

MeasureTime frameDescription
voluntary muscularityWeek 10voluntary muscularity measured by the quotation of Held and Pierrot Deseilligny

Secondary

MeasureTime frameDescription
Spasticity scoreWeek 10Ashworth scale modified for spasticity

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026